Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
ABCB1 overexpression
Cancer:
Non Small Cell Lung Cancer
Drug:
paclitaxel
(
Bcl2 inhibitor
,
Tubulin polymerization promoter
)
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Source:
Mol Ther Nucleic Acids
Title:
CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC
Excerpt:
Compared with NCI-H23, NCI-H23-TXR had higher expression levels in P-glycoprotein (P-gp) and multidrug resistance protein 7 (ABCC10).
DOI:
10.1016/j.omtn.2019.06.017
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login